Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent
Salloum RG et al. – Among an insured population, wide variation regarding the use of surveillance care was found by age and relative to guideline recommendations. Breast cancer survivors were found to have high rates of both guideline–recommended recurrence testing and non–guideline–recommended metastatic testing. Only approximately 50% of colorectal cancer survivors received recommended tests but greater than 67% received metastatic testing.